|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 07:00 21-May-2013 | SHP | Transaction in Own Shares | PRN | +3.96% |
| 07:00 16-May-2013 | SHP | Transaction in Own Shares | PRN | +3.31% |
| 16:58 09-May-2013 | SHP | Shire Wins Patent Trial Against Watson concerning LIALDA | PRN | +7.71% |
| 07:00 09-May-2013 | SHP | Transaction in Own Shares | PRN | +7.71% |
| 15:00 08-May-2013 | SHP | Purchase of Shares by Employee Benefit Trust | PRN | +7.14% |
| 07:00 08-May-2013 | SHP | Transaction in Own Shares | PRN | +7.14% |
| 07:00 07-May-2013 | SHP | Transaction in Own Shares | PRN | +4.14% |
| 14:45 03-May-2013 | SHP | Director?s Share Dealings | PRN | -1.46% |
| 07:00 03-May-2013 | SHP | Transaction in Own Shares | PRN | -1.46% |
| 12:00 02-May-2013 | SHP | New CEO reports Q1 and sets out strategy for growth | PRN | -4.57% |
| 07:00 02-May-2013 | SHP | Transaction in Own Shares | PRN | -4.57% |
| 12:00 01-May-2013 | SHP | Total Voting Rights | PRN | -6.24% |
| 16:00 30-Apr-2013 | SHP | Results of the 2013 Annual General Meeting | PRN | -4.75% |
| 07:00 30-Apr-2013 | SHP | Transaction in Own Shares | PRN | -4.75% |
| 16:30 29-Apr-2013 | SHP | Director Declaration | PRN | -3.03% |
| 07:00 26-Apr-2013 | SHP | Transaction in Own Shares | PRN | -1.96% |
| 14:26 25-Apr-2013 | SHP | Shire Settles INTUNIV Litigation with Actavis and Watson | PRN | -0.45% |
| 07:00 25-Apr-2013 | SHP | Transaction in Own Shares | PRN | -0.45% |
| 07:00 24-Apr-2013 | SHP | Transaction in Own Shares | PRN | +1.01% |
| 07:00 23-Apr-2013 | SHP | Transaction in Own Shares | PRN | +1.84% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds